Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GPO investigation goes public

This article was originally published in The Gray Sheet

Executive Summary

The New York Times is understood to be working on a three-part series focusing on hospital group purchasing organization contracting practices. The Senate Judiciary/Antitrust Subcommittee is expected to hold hearings on the topic this spring. The investigation grew out of allegations by the Medical Device Manufacturers Association that GPO contracts foreclose the market for their products (1"The Gray Sheet" Dec. 17, 2001, p. 24). The Times reportedly has submitted questionnaires to manufacturers in the device and pharmaceutical industries on contracting practices as part of its research for the article...

You may also be interested in...



Senate Antitrust Panel Hearings On GPO Practices Could Convene In February

The Senate Judiciary/Antitrust, Business Rights and Competition Subcommittee will likely hold hearings on healthcare group purchasing practices in February 2002, according to the Medical Device Manufacturers Association

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel